Sonoma Pharmaceuticals, Inc.·4

Jan 8, 4:16 PM ET

DVONCH JEROME J 4

4 · Sonoma Pharmaceuticals, Inc. · Filed Jan 8, 2021

Insider Transaction Report

Form 4
Period: 2021-01-07
DVONCH JEROME J
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2021-01-07+27,77727,777 total
    Exercise: $8.03Exp: 2031-01-07Common Stock (27,777 underlying)
Footnotes (2)
  • [F1]The options vest one third each on 01/07/2022, 01/07/2023 and 01/07/2024, or upon a change of control.
  • [F2]The options were awarded and granted to Mr. Dvonch for services performed.

Documents

1 file
  • 4
    ownership.xmlPrimary